Drug Development for Infectious Diseases
A special issue of Pathogens (ISSN 2076-0817).
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 230
Special Issue Editors
Interests: immunology; infection; cellular immunology; Chagas disease; leishmaniasis; Cryptococcus neoformans; Cryptococcus gattii; polyssacharides; macrophages; immunomodulation
Special Issues, Collections and Topics in MDPI journals
Interests: antiparasitic drugs; neglected infectious diseases
Interests: parasitic infections; immunoparasitology; leishmaniosis; apoptosis; immunomodulation of macrophage activity; leishmanicidal and immunomodulatory activities
Interests: glycobiology of fungi
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Infectious diseases are caused by microorganisms (protozoa, bacteria, helminths, fungi and virus) with a complex life cycle that sometimes involves more than one host. They present significant morbidity and mortality rates that can impact the life expectancy of humans and animals. Although they can be present in several parts of the world, they are prevalent in South America, Central America, Africa and Asia. The most affected populations are those with lower purchasing power and those in precarious sanitary conditions. Although some have already been described hundreds of years ago, for most of them, there are no effective chemotherapeutics. Thus, the search for new molecules that can eliminate or alleviate this scourge of mostly poor populations is urgent and necessary. The purpose of this Special Issue is to bring together original research articles, reviews and case reports on molecules with chemotherapeutic potential for the treatment of infectious diseases. Thus, we are interested in works about new natural or synthetic molecules or even molecules that are already known and used in other situations that can be repositioned.
Dr. Debora Decote-Ricardo
Dr. Marco Edilson Freire De Lima
Dr. Lucia Pinto da Silva
Dr. Célio Geraldo Freire-de-Lima
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- infection
- drug development
- parasitic chemotherapy
- natural products
- drug repositioning
- protozoa
- bacteria
- fungi
- virus
